GlassScriptPhysician profile
Talitha Katches
NPI 1801460126
$2,738.20
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.38 · 2022: $1,002 · 2023: $662 · 2024: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.38 |
| Education | $194.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $454.10 | 2022-2024 | Tremfya |
| Abbvie INC. | $372.79 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $370.88 | 2022-2024 | Absorica Ld, Winlevi, Ilumya |
| Lilly USA, LLC | $334.36 | 2021-2024 | Taltz, Olumiant, Zepbound |
| Janssen Scientific Affairs, LLC | $233.69 | 2022 | |
| Genzyme Corporation | $221.04 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $129.77 | 2022-2024 | Dupixent |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $72.93 | 2023-2024 | Jublia |
| Dermavant Sciences, INC. | $63.82 | 2023-2024 | Vtama |
| Pfizer INC. | $57.85 | 2023-2024 | |
| Biofrontera INC. | $56.92 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Leo Pharma INC. | $45.82 | 2022-2024 | Adbry |
| Verrica Pharmaceuticals INC. | $43.55 | 2024 | Ycanth |
| Ucb, INC. | $42.00 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $35.71 | 2022 | |
| Amgen INC. | $24.94 | 2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $21.95 | 2024 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $20.02 | 2024 | Sotyktu |
| Hologic Sales and Service, LLC | $19.81 | 2021 | |
| Galderma Laboratories, L.P. | $17.26 | 2023 | Epsolay, Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talitha Katches listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.